Objective: To determine if two pre-race screening tools (abbreviated tool of two open-ended pre-race medical screening questions [ABBR] vs. a full pre-race medical screening tool [FULL]) identify running race entrants at higher risk for medical encounters (MEs) on race day.
Methods: 5771 consenting race entrants completed both an ABBR and a FULL pre-race screening questionnaire for the 2018 Comrades Marathon (90 km). ABBR tool questions were (1) allergies, and (2) known medical conditions and/or prescription medication use. The FULL tool included multiple domains of questions for chronic diseases including cardiovascular disease (CVD), symptoms, risk factors, allergies and medication use. ABBR responses were manually coded and compared to the FULL tool. The prevalence (%: 95%CI), and the test for equality of prevalence of entrants identified by the ABBR vs. FULL tool is reported.
Results: The ABBR identified fewer entrants with allergies (ABBR = 7.9%; FULL = 10.4%: p = 0.0001) and medical conditions/medication use (ABBR = 8.9%; FULL = 27.4%: p = 0.0001). The ABBR tool significantly under-reported entrants with history of cardiovascular disease (CVD), CVD risk factors, other chronic diseases and prescription medication vs. the FULL tool (p = 0.0001). The ABBR tool identified fewer entrants in the "high" (ABBR = 3.4%; FULL = 12.4%) and "very high" risk (ABBR = 0.5%; FULL = 3.4%) categories for race day MEs (p = 0.0001).
Conclusions: An abbreviated pre-race screening tool significantly under-estimates chronic medical conditions, allergies, and race entrants at higher risk for MEs on race day, compared with a full comprehensive screening tool. We recommend that a full pre-race medical screening tool be used to identify race entrants at risk for MEs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10946828 | PMC |
| http://dx.doi.org/10.1111/sms.14462 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pre-race medical clearance in 60,609 distance running race entrants: which entrants sought clearance, what physicians did, and what was the outcome? SAFER XXXVII.
J Sports Med Phys Fitness
January 2025
Sport, Exercise Medicine and Lifestyle Institute (SEMLI), Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa -
Background: Medical clearance is often recommended for athletes prior to endurance exercise. The primary aim was to determine the percentage (%) of race entrants that sought medical clearance prior to participation in endurance running events, describe the diagnostic modalities used by doctors to assess entrants seeking medical clearance, and the clearance advice given. Secondary aims were to investigate the factors associated with seeking and outcome of clearance.
View Article and Find Full Text PDFBoston Marathon athlete performance outcomes and intra-event medical encounter risk associated with low energy availability indicators.
Br J Sports Med
November 2024
Harvard Medical School, Boston, Massachusetts, USA.
Article Synopsis
- The study aimed to investigate the relationship between self-reported indicators of low energy availability (LEA-I) and race performance as well as medical incidents during the Boston Marathon.
- A survey of 1,030 runners revealed a higher prevalence of LEA-I in females (42.5%) compared to males (17.6%), with athletes experiencing LEA-I performing worse in terms of race times and placement.
- The findings indicated that runners with LEA-I had significantly increased risks of medical encounters during the race, underscoring the negative impacts of low energy availability on marathon performance and health.
Factors associated with a history of acute traumatic cycling injuries in 60 941 cycling race entrants in South Africa: SAFER study XLII.
Inj Prev
October 2024
Sport, Exercise Medicine and Lifestyle Institute (SEMLI), Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
Article Synopsis
- The study aimed to explore factors linked to acute traumatic cycling injuries (ATCIs) among entrants of a 109 km cycling race, focusing on incidents within the previous year.
- It analyzed data from 60,941 participants from 2016 to 2020, collecting information through medical screening questionnaires about cycling history, demographics, and health conditions.
- Results highlighted that longer participation in distance cycling, higher weekly cycling distances, and certain health issues (like chronic diseases and history of collapse or cramping) significantly increased the risk of sustaining ATCIs.
Hyperthermia and Exertional Heatstroke During Running, Cycling, Open Water Swimming, and Triathlon Events.
Open Access J Sports Med
September 2024
Korey Stringer Institute, Department of Kinesiology, University of Connecticut, Storrs, CT, USA.
Article Synopsis
- A study evaluated the understanding of hyperthermia and exertional heatstroke (EHS) in endurance sports like running, cycling, swimming, and triathlons, revealing a gap in research on their differences and similarities.
- Research involved reviewing 1192 articles and identifying 80 relevant studies, which showed that medical teams mostly recognized hyperthermia and EHS in running and triathlon events (58.8 to 85.7%), but not in cycling and open water swimming (0 to 20%).
- The findings aim to aid race directors in providing safety advice and assist medical teams in effectively allocating resources for managing hyperthermia and EHS during competitions.
The RACE Act and Pediatric Trials of Adult Cancer Drugs.
Pediatrics
October 2024
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Background And Objectives: Adult cancer drugs have historically been exempted from pediatric testing requirements. In 2017, Congress passed the Research to Accelerate Cures and Equity (RACE) for Children Act to expand mandatory pediatric testing to cancer drugs; the law took effect in 2020. With this study, we sought to evaluate how the pediatric testing of molecularly targeted adult cancer drugs changed after the RACE Act.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!